ASCO

For demo purposes only – Not for redistribution

ASCO Tumor Board

Management of Non-muscle Invasive Bladder Cancer

In this tumor board, experts explore multidisciplinary treatment approaches for a 73-year-old woman with grade 3, pT1 transitional cell carcinoma. The cancer recurred upon initial treatment. Research evidence, as well as patient and tumor-related factors that impact treatment selection are discussed in depth.

Learning Objectives

Upon participation in this activity, learners will be better able to:

  • Review the pathological determinants of recurrence, progression and understaging in patients with non-muscle invasive bladder cancer
  • Evaluate appropriate strategies for management of patients with high-risk NMIBC
View full screen

Faculty

Robert Dreicer, MD, MS, FACP, FASCO

Robert Dreicer, MD, MS, FACP, FASCO

University of Virginia

Seth P. Lerner, MD

Seth P. Lerner, MD

Baylor College of Medicine

Hikmat Al-Ahmadie, MD

Hikmat Al-Ahmadie, MD

Memorial Sloan Kettering Cancer Center

Simon Hughes, MD

Guy's and St Thomas' NHS Foundation Trust

MedEngine is provided by Springer Healthcare. Part of Springer Nature Group.
Terms & conditions
Privacy policy
Manage cookies/Do not sell my data